Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $46.2B |
| FY2017, ended Dec 31, 2017 | $39.9B |
| FY2018, ended Dec 31, 2018 | $34.8B |
| FY2019, ended Dec 31, 2019 | $48.0B |
| FY2020, ended Dec 31, 2020 | $31.0B |
| FY2021, ended Dec 31, 2021 | $36.0B |
| FY2022, ended Dec 31, 2022 | $40.6B |
| FY2023, ended Dec 31, 2023 | $39.1B |
| FY2024, ended Dec 31, 2024 | $60.9B |
| FY2025, ended Dec 31, 2025 | $61.2B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $67.2B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $13.1B |
| FY2017, ended Dec 31, 2017 | $13.7B |
| FY2018, ended Dec 31, 2018 | $14.1B |
| FY2019, ended Dec 31, 2019 | $13.2B |
| FY2020, ended Dec 31, 2020 | $11.7B |
| FY2021, ended Dec 31, 2021 | $16.6B |
| FY2022, ended Dec 31, 2022 | $19.2B |
| FY2023, ended Dec 31, 2023 | $15.3B |
| FY2024, ended Dec 31, 2024 | $15.1B |
| FY2025, ended Dec 31, 2025 | $16.9B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $18.3B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $708M | $1.88B |
| FY2017, ended Dec 31, 2017 | $183M | $1.41B |
| FY2018, ended Dec 31, 2018 | $1.61B | $2.14B |
| FY2019, ended Dec 31, 2019 | $2.19B | $2.48B |
| FY2020, ended Dec 31, 2020 | $119M | $2.84B |
| FY2021, ended Dec 31, 2021 | $1.78B | $4.43B |
| FY2022, ended Dec 31, 2022 | $2.55B | $3.35B |
| FY2023, ended Dec 31, 2023 | $2.39B | $4.17B |
| FY2024, ended Dec 31, 2024 | $2.61B | $3.01B |
| FY2025, ended Dec 31, 2025 | $3.06B | $2.89B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $3.60B | $3.08B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $684M |
| FY2017, ended Dec 31, 2017 | $264M |
| FY2018, ended Dec 31, 2018 | $3.28B |
| FY2019, ended Dec 31, 2019 | $185M |
| FY2020, ended Dec 31, 2020 | $1.18B |
| FY2021, ended Dec 31, 2021 | $1.14B |
| FY2022, ended Dec 31, 2022 | $745M |
| FY2023, ended Dec 31, 2023 | $83.0M |
| FY2024, ended Dec 31, 2024 | $88.0M |
| FY2025, ended Dec 31, 2025 | $63.0M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $918M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $38.9B |
| FY2017, ended Dec 31, 2017 | $36.9B |
| FY2018, ended Dec 31, 2018 | $37.3B |
| FY2019, ended Dec 31, 2019 | $34.4B |
| FY2020, ended Dec 31, 2020 | $34.7B |
| FY2021, ended Dec 31, 2021 | $33.3B |
| FY2022, ended Dec 31, 2022 | $31.8B |
| FY2023, ended Dec 31, 2023 | $32.1B |
| FY2024, ended Dec 31, 2024 | $31.9B |
| FY2025, ended Dec 31, 2025 | $32.0B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $33.1B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 0.2% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 2.23B |
| FY2017, ended Dec 31, 2017 | 2.21B |
| FY2018, ended Dec 31, 2018 | 2.26B |
| FY2019, ended Dec 31, 2019 | 2.27B |
| FY2020, ended Dec 31, 2020 | 2.26B |
| FY2021, ended Dec 31, 2021 | 2.27B |
| FY2022, ended Dec 31, 2022 | 2.25B |
| FY2023, ended Dec 31, 2023 | 2.22B |
| FY2024, ended Dec 31, 2024 | 2.22B |
| FY2025, ended Dec 31, 2025 | 2.22B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 2.23B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Sold for cash |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $0 | $0 |
| FY2017, ended Dec 31, 2017 | $250M | $0 |
| FY2018, ended Dec 31, 2018 | $273M | — |
| FY2019, ended Dec 31, 2019 | $2.00M | — |
| FY2020, ended Dec 31, 2020 | $50.0M | — |
| FY2021, ended Dec 31, 2021 | $0 | — |
| FY2022, ended Dec 31, 2022 | $368M | — |
| FY2023, ended Dec 31, 2023 | $522M | — |
| FY2024, ended Dec 31, 2024 | $7.00M | — |
| FY2025, ended Dec 31, 2025 | $0 | — |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | — | — |
Valuation
At current price- Market Cap
- $75.4B
- P/E
- 20.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 4.1×
- Price / Book
- 2.4×
- EV / EBITDA
- 13.8×
Growth
Trailing 12 months- Revenue (TTM)
- $18.3B
- Revenue Growth YoY
- 11.7%
- Revenue CAGR 3Y
- −4.1%
- Revenue CAGR 5Y
- 7.7%
- EPS Growth YoY
- 32.8%
- Net Income Growth YoY
- 32.1%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 29.0%
- Net Margin
- 19.6%
- FCF Margin
- 16.8%
- Return on Equity
- 11.6%
Earnings
Trailing 12 months- Net Income
- $3.60B
- EPS (diluted)
- $1.62
- EBITDA
- $7.81B
- Operating Income
- $5.31B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $918M
- Total Debt
- $33.1B
- Net Debt
- $32.2B
- Total Assets
- $75.4B
- Total Liabilities
- $42.6B
- Shareholders' Equity
- $31.6B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $6.73B
- Capital Expenditure
- $3.65B
- Free Cash Flow
- $3.08B
Dividends and risk
Last 12 months- Dividend Yield
- 3.5%
- Dividend / Share
- $1.18
- Beta (5Y)
- 0.59
Every ratio is calculated from the company’s reported figures.